MEET THE EXPERTS
Our teamMeet Our Experienced Team
Our management team and Scientific Advisory Board bring decades of experience and cutting-edge knowledge to the forefront in discovering and developing leading-edge medicines. Collectively, we are dedicated to discovering and developing new therapies that will change the world of oncology, dermatology, and more.
Leadership Team
Scientific Advisory Board
Manmeet Ahluwalia, MD, FACP, MBA
Chief of Solid Tumor Medical Oncology, Deputy Director and Chief Scientific Officer, Miami Cancer Institute
Daniel Cahill, MD, PhD
Professor, Neurosurgery & Oncology, Harvard Medical
Director of Neuro-Oncology, Massachusetts General Hospital
Director of Neuro-Oncology, Massachusetts General Hospital
George Demetri, MD
Professor, Harvard, Dana Farber; Director of Sarcoma Center
BOD & SAB, Blueprint Medicines
BOD & SAB, Blueprint Medicines
Lori Kunkel, MD
Former CMO & BOD, LoxoOncology; Former CMO, Pharmacyclics
BOD/SAB, Elevation, Rain, Maverick, Nurix, Curis
BOD/SAB, Elevation, Rain, Maverick, Nurix, Curis
Michael Lim, MD
Chair of Neurosurgery at Stanford Medicine; former professor of neurosurgery & oncology, Johns Hopkins
David Reardon, MD
Former President of the Society for Neuro-Oncology
Director of Center for Neuro-Oncology, DFCI
Director of Center for Neuro-Oncology, DFCI
John Sampson, MD, PhD, MBA, MHSc
Professor & former Chair of Neurosurgery, Duke University
Member, National Academy of Medicine
Member, National Academy of Medicine
Dave Solit, MD
Geoffrey Beene Chair; Director, Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Katherine Warren, MD
Clinical Director of Pediatric Neuro-Oncology, Boston Children’s/DFCI; former Head of Pediatric Neuro-Oncology Group, National Cancer Institute
Board of Directors
Want to know more? Contact us today.